{"disease":{"id":"adrenoleukodystrophy","name":"adrenoleukodystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT04090268","title":"Precision Exercise in Children With Malignant Hemopathies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT04675749","title":"Quality of Life in Women with X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT05939232","title":"Registry of X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT02171104","title":"MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":149,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06224413","title":"A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT03231878","title":"A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Minoryx Therapeutics, S.L.","has_results":false},{"nct_id":"NCT03278899","title":"A Study to Prospectively Assess Disease Progression in Male Children With X-ALD","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"NeuroVia, Inc.","has_results":false},{"nct_id":"NCT04687007","title":"SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT03852498","title":"A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true},{"nct_id":"NCT01896102","title":"A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true},{"nct_id":"NCT03727555","title":"IT and IV Lentiviral Gene Therapy for X-ALD","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT04973657","title":"A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Viking Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05003648","title":"Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT02595489","title":"A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04528706","title":"A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":13,"lead_sponsor_name":"Minoryx Therapeutics, S.L.","has_results":false},{"nct_id":"NCT06030648","title":"MT2022-01: MSCs for ALD","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT03367546","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04303416","title":"Plasma Exchange With Albumin in AMN Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Pujol, Aurora, M.D.","has_results":false},{"nct_id":"NCT02233257","title":"Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Minnesota","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}